Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
Last trade$1.99
Day change+$0.075 (+3.93%)
Day range$1.84 – $2.06
Volume23,536
Market cap$18M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$18.14M
Price / earnings
—
Price / book
1.68×
Price / sales
—
EV / sales
—
EV / EBITDA
-0.56×
Profitability
Earnings per share
-$2.95
Return on assets
-228.73%
Return on equity
-260.37%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
3.25×
Quick ratio
3.25×
Cash ratio
2.63×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$28.04M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for MODD, quarterly periods
Line item
Q1 FY2027 Jun 30, 2026
Q4 FY2026 Mar 31, 2026
Q3 FY2026 Dec 31, 2025
Q2 FY2026 Sep 30, 2025
Q1 FY2026 Jun 30, 2025
Q4 FY2025 Mar 31, 2025
Q3 FY2025 Dec 31, 2024
Q2 FY2025 Sep 30, 2024
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$0
$0
$0
$0
$0
$0
Selling, general and administrative
$2.17M
$1.84M
$1.84M
$2.24M
$1.67M
$1.04M
$1M
$1.29M
Research and development
$4.37M
$3.84M
$5.41M
$5.59M
$5.13M
$3.94M
$3.85M
$3.7M
Total operating expenses
$6.54M
$5.68M
$7.24M
$7.83M
$6.8M
$4.98M
$4.85M
$5M
Operating income
-$6.54M
-$5.68M
-$7.24M
-$7.83M
-$6.8M
-$4.98M
-$4.85M
-$5M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
-$6.49M
-$6.39M
-$7.36M
-$7.79M
-$6.7M
-$4.93M
-$4.8M
-$4.95M
Income taxes
$0
$0
$0
$2K
$0
$0
$0
$2K
Net income
-$6.49M
-$6.39M
-$7.36M
-$7.79M
-$6.7M
-$4.93M
-$4.8M
-$4.96M
Net income attributable to common shareholders
-$6.49M
-$6.39M
-$7.36M
-$7.79M
-$6.7M
-$4.93M
-$4.8M
-$4.96M
EBITDA
-$6.04M
-$5.24M
-$6.81M
-$7.44M
-$6.39M
-$4.65M
-$4.57M
-$4.74M
Basic earnings per share
-$1.19
-$1.95
-$3.30
-$4.20
-$3.70
-$3.53
-$3.90
-$4.20
Diluted earnings per share
-$1.19
-$1.95
-$3.30
-$4.20
-$3.70
-$3.53
-$3.90
-$4.20
Recent news
Company coverage with links to the original publishers.
The AI-IoT chipset market is expected to grow rapidly, driven by advancements in AI-driven data analytics, digital twins, and blockchain integration. The market is segmented by end-use applications and technologies, with opportunities across consumer electronics, automotive, healthcare, and industrial sectors.
Modular Medical's (MODD) latest U.S. patent is likely to protect the company's technology addressing pairing and allow clinicians to easily upload and review patients' data.
Modular Medical, Inc. (MODD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Gainers
SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) gained 53.1% to $0.3264 after the company received an Innovation Technology contract from Vizient for its novel AI-driven precision heart disease tests.
Verve Therapeutics, Inc. (NASDAQ: VERV) jumped 27% to $11.95. Eli Lilly said it will acquire rights under Beam Therapeutics’ amended collaboration and license agreement with Verve, including rights to co-develop and co-commercialize Verve's base editing programs for cardiovascular disease.
BioVie Inc. (NASDAQ: BIVI) rose 23.6% to $4.7840.
Wolfspeed, Inc. (NYSE: WOLF) jumped 22.7% to $34.02 after the company reported first-quarter earnings.
Repligen Corporation (NASDAQ: RGEN) gained 20.5% to $137.65 following better-than-expected results.
Mullen Automotive, Inc. (NASDAQ: MULN) rose 20.1% to $0.3051.
YanGuFang International Group Co., Ltd. (NASDAQ: YGF) gained 19.5% to $2.81.
Shutterstock, Inc. (NYSE: SSTK) climbed 18.6% to $40.71 after the company posted upbeat third-quarter results and raised FY23 outlook.
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) rose 17.7% to $23.21 following third-quarter results.
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares gained 17.5% to $0.1090 after the company announced it has completed the divestiture of AVTX-800 Series.
Pinterest, Inc. (NYSE: PINS) shares rose 16.9% to $29.34 after the company reported better-than-expected third-quarter financial results and issued guidance.
Two Harbors Investment Corp. (NYSE: TWO) climbed 16.8% to $11.74 following quarterly results.
Conduit Pharmaceuticals Inc. (NASDAQ: CDT) rose 16.5% to $1.83.
Femasys Inc. (NASDAQ: FEMY) gained 16.5% to $1.62.
Modular Medical, Inc. (NASDAQ: MODD) jumped 15% to $1.23.
Evaxion Biotech A/S (NASDAQ: EVAX) climbed 14.8% to $1.09.
Insperity, Inc. (NYSE: NSP) gained 14.3% to $110.31 following upbeat results.
EUDA Health Holdings Limited (NASDAQ: ...
The Dow Jones closed lower by over 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Tecogen
The Trade: Tecogen Inc. (OTC: TGEN) Director Earl R Lewis acquired a total of 25,000 shares an average price of $0.91. To acquire these shares, it cost ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.